In the last decade, direct and indirect costs of disease have been of great interest. Because of this we recognize that every choice in the health field is not an independent variable, but is strongly related to the economic resources available to a society and the historical context . The great majority of studies, particularly those focused on chronic diseases, have suffered from important methodological problems. In studying the costs, one should not consider a disease to be an abstract entity, as if the clinical modifications were “in vitro” occurrences instead of a complex reality constituted by a puzzle of vital events. Therefore, a correct methodological basis is essential to compute the realistic costs of a chronic disease.
KeywordsNursing Home Indirect Cost Dementia Care Concurrent Disease National Health Care System
Unable to display preview. Download preview PDF.
- 1.Levorato A, Rozzini R, Trabucchi M (1994) I costi della vecchiaia. Mulino, BolognaGoogle Scholar
- 3.National Institute on Aging (1993) Progress report on Alzheimer’s disease. NIH publication no 93-3409Google Scholar
- 6.Bianchetti A, Trabucchi M (1994) L’impatto economico per 1a demenza: una ipotesi per l’Italia. Giorn Geront 42: 687–692Google Scholar
- 7.Trabucchi M, Govoni S, Bianchetti A (1995) Socio-economic aspects of Alzheimer’s disease treatment. In: Giacobini E, Becker R (eds) Alzheimer disease: therapeutic strategies. Birkhäuser, Boston, pp 459–463Google Scholar
- 16.Greenfield S, Blano DM, Elashoff RM (1987) Development and testing of a new index of comorbidity. Clin Res 35: 346AGoogle Scholar
- 17.Ostbye T, Crosse E (1994) Net economic costs of dementia in Canada. Can Med Assoc J 151: 1457–1464Google Scholar
- 20.Max W (1993) The economic impact of Alzheimer’s disease. Neurology 43[Suppl 4]: S6–S10Google Scholar